MHRA Drug Safety Update
Guidelines for approved choice of blood glucose testing strips, meters and lancets
SYB Shared Care Protocol for Epilepsy in Adults [UPDATED]
SYB Shared Care Protocol for the treatment of Parkinson’s disease [UPDATED]

April 2022

Patient Information Leaflet: Unlicensed and ‘Off-label’ medicines [UPDATED]
Patient Information Leaflet: Trial of stopping your overactive bladder drug [UPDATED]
Wound Care
Ganciclovir 0.15% Eye Gel Amber-G guideline [UPDATED]
Shared Care Guideline for Lithium Therapy [UPDATED]
Morphine Injection
Primary Care Medicines Optimisation Scheme QIPP areas involving specific brands or preparations 22/23

March 2022

Calcium and Vitamin D, and Vitamin D Summary of formulary choices in adults over 18 years [UPDATED]
Sheffield Area Prescribing Group (APG) shared care protocol for topical testosterone replacement therapy in post-menopausal women
Guidelines with extended review dates
COVID-19 antivirals: reporting to the UK COVID-19 Antivirals Pregnancy Registry

March 2022 Enc - Guidelines with extended review dates

February 2022

Possible Alternatives to Unlicensed Specials [UPDATED]
Calcium and Vitamin D (combination) and Vitamin D Summary of Formulary Choices in Adults over 18 years [UPDATED]
Osteoporosis Drug Holiday Guidelines for GPs [UPDATED]

January 2022

Liothyronine (including Armour® Thyroid and liothyronine combination products) Area Prescribing Committee Position Statement [NEW]
Guidance for Oral Paracetamol dosing [UPDATED]
Management of Osteoporosis and Fragility Fracture Risk Barnsley Guideline [UPDATED]
SYB Trans man and Trans woman prescribing guidelines [UPDATED]
Haloperidol (Haldol®): reminder of risks when used in elderly patients for the acute treatment of delirium

APC Memos 2021

December 2021

Needles for pre-filled and resuable pens Area Prescribing Committee Position Statement [NEW]
Adult Iron Deficiency Anaemia (IDA) Pathway [NEW]
Adrenaline auto-injectors: reminder for prescribers to support safe and effective use

November 2021

Guidance on the Prescribing of Oral Nutritional Supplements in Dysphagia [NEW]
Guidance for the Appropriate Prescribing for Phenylketonuria (PKU) [NEW]
Management of stable COPD [MINOR UPDATE] #
Drug Management of Neuropathic Pain [UPDATED]
Ranitidine Liquid Shortage: Barnsley Guidance on Alternatives to Ranitidine Liquid for GastroOesophageal Reflux Disease in Babies and Children [UPDATED]
Chloral hydrate, cloral betaine (Welldorm): restriction of paediatric indication

September and October 2021

Adult Iron Deficiency Anaemia (IDA) Pathway [NEW]
Trial of Stopping your Overactive Bladder Drug Patient Information Leaflet [NEW]
Palliative Care Guideline: Management of Seizures/Epilepsy in Patients Unable to Swallow Oral Medication [UPDATED]
Palliative Care Guideline: Ketamine [UPDATED]
Guidance on the use of strong opioids in Barnsley [UPDATED]
Sayana® Press – Guidance for Primary Care [UPDATED]
Barnsley Continence Guide [UPDATED]
Chronic Coronary Syndrome (Previously Known as Stable Angina) – Management [UPDATED]
Guideline for the Management of Children and Young Adults with Suspected Vitamin D Deficiency in Primary Care (Full and Summary guideline) [UPDATED]
Barnsley Asthma Guideline for adults – including algorithm and inhaler chart [UPDATED]

September and October 2021 Enc - Final Barnsley Asthma Guideline for adults

July and August 2021

Clinical Guideline: proton pump inhibitors and alternatives to subcutaneous ranitidine [NEW]
Fentanyl and buprenorphine skin patches: How to use and dispose of them safely [UPDATED]
Linaclotide (Constella®) Amber-G guideline [UPDATED]
Aromatase inhibitors Amber-G Guideline [UPDATED]
Nalmefene (Selincro®) Amber-G Guideline [UPDATED]
Liver Function Tests
Chloramphenicol eye drops containing borax or boric acid buffers: use in children younger than 2 years

June 2021

GLP-1 agonists: Liraglutide (Victoza®) Lixisenatide (Lyxumia®▼) Dulaglutide (Trulicity®) Semaglutide (Ozempic®) Amber-G guideline [UPDATED]
Demeclocycline Hydrochloride Shared Care Guideline for the treatment of chronic hyponatraemia associated with the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) [UPDATED]
SYB Shared Care Protocol for Epilepsy in Adults [UPDATED]
AMAC Unit Discharge Information Discharge letters (D1s)
Levothyroxine: new prescribing advice for patients who experience symptoms on switching between different levothyroxine products

May 2021

Protocols for initiating FreeStyle Libre 2® for glucose monitoring in ADULTS and CHILDREN and GP contacts/agreements [UPDATED]
Guidance for the use of Diltiazem 2% cream/ointment in the management of anal fissures [UPDATED]
Chloramphenicol eye drops in children under 2 years
Reminder – Dosages on liquid medicines
Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect when mixed, leading to an increased risk of aspiration

April 2021

Barnsley Antibiotic Formulary Choices Poster 2020/21 [NEW]
Primary Care Prescribing Guidance: Fat Emulsions for the Purpose of Oral Nutritional Support [NEW]
Oral Nutritional Supplements (ONS) Prescribing Guidelines in Primary Care: Adults aged 18 years and over [UPDATED]
Management of Low Vitamin D Level in Adults (18 years and over) [UPDATED]
Anti-emetic guidelines [UPDATED]
Inhaled Budesonide for Adults (50 years and over) with COVID-19
Adding Hospital Only Medications to Patients Records

March 2021

Nutrition and Wound Care – a guide for service users and carers [NEW]
Guidance on the most appropriate and cost effective prescribing of infant formula in primary care [UPDATED]
Phyllocontin® Discontinuation: Guidance for Switching Phyllocontin® (aminophylline MR tablets) to Uniphyllin Continus® (theophylline MR tablets) [NEW]
Dapagliflozin for heart failure with reduced ejection fraction (HFrEF)
Pregabalin (Lyrica®): reports of severe respiratory depression

February 2021

Guide to Prescribing Thickeners for Adults [UPDATED]
Adult Primary Care Antimicrobial Treatment Guidelines [MINOR UPDATE]
Phyllocontin® Discontinuation
Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery

January 2021

Management of Allergic Rhinitis in Primary Care [UPDATED]
Bath Additives and Shower Emollients Area Prescribing Committee Position Statement [NEW]
Systemic and inhaled fluoroquinolones: small risk of heart valve regurgitation; consider other therapeutic options first in patients at risk
Erythromycin: caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban
Erythromycin: update on known risk of infantile hypertrophic pyloric stenosis

APC Memos 2020

December 2020

SSRI section of the formulary
Traffic Light Classifications

November 2020

Treatment of overactive bladder in women guidance [UPDATED]
Shared Care / Amber-G Guidelines
Melatonin formulary preparations
Nifedipine formulary preparations
Warfarin and other anticoagulants: monitoring of patients during the COVID-19 pandemic

October 2020

Public Health Nursing 0-19 Service Prescribing Formulary [NEW]
Oral Ranitidine out of stock guidance [NEW
Febuxostat Prescribing Guidelines [UPDATED]
Guidance for the use of Linezolid in the Treatment of Pneumonia and Severe Skin and Soft Tissue Infections [UPDATED]
Management of stable COPD Algorithm

October 2020 Enclosure - PrescQipp Hot Topics - Lowering the Inhaler Carbon Footprint

September 2020

Primary care prescribing guidelines: advisory, minimum and gold [UPDATED] and Community pharmacy key dispensing guidelines [UPDATED]
Steroid Emergency Card NPSA alert
Priadel® tablets (lithium carbonate)
Stimulant laxatives (bisacodyl, senna and sennosides, sodium picosulfate) available over-thecounter: new measures to support safe use
Denosumab 60mg (Prolia®): increased risk of multiple vertebral fractures after stopping or delaying ongoing treatment
Emollients and risk of severe and fatal burns: new resources available

August 2020

Anticoagulation for Stroke Prevention in Non-Valvular Atrial Fibrillation: Joint primary and secondary care guidance [UPDATED]
Drugs prolonging the QTc interval and palliative care [UPDATED]
Use of Calcium and Vitamin D post Fragility Fracture [NEW]

July 2020

Alimemazine APC Position Statement [NEW]
Prescribing of SGLT2 Inhibitors during the COVID-19 pandemic [NEW]
Primary Care Prescribing Guidelines (Advisory, Minimum and Gold) and Community Pharmacy Key Dispensing Guidelines [UPDATED]
Cyproterone acetate: new advice to minimise risk of meningioma
Direct-acting oral anticoagulants (DOACs): reminder of bleeding risk, including availability of reversal agents

June 2020

Barnsley Guideline for using Antiplatelet drugs in the prevention and treatment of Cardiovascular and Cerebrovascular diseases [UPDATED]
Rubefacients (excluding topical NSAIDS and Capsaicin) Area Prescribing Committee Position Statement [NEW]
BEST COVID-19 Medicines and Prescribing Information

March 2020

Lidocaine 5% Medicated Plasters Position Statement [NEW]
Diagnosing diabetes which test should be used? [UPDATED]
Insomnia Management Guideline [UPDATED]
Using Standardised Strengths of Unlicensed Liquid Medicines in Children [UPDATED]

February 2020

Switching between Oral Anticoagulants [NEW]
Anticoagulation for Stroke Prevention in Non-Valvular Atrial Fibrillation: Joint primary and secondary care guidance [UPDATED]
Adult Primary Care Antimicrobial Treatment Guidelines [UPDATED]
Algorithm for the Management of Glaucoma [UPDATED]
Quetiapine: use plain tablets QIPP Detail Aid [UPDATED]
E-cigarette use or vaping: reporting suspected adverse reactions, including lung injury

January 2020